Director Mark S. Blumenkranz resigns from KALA BIO board immediately

KALA BIO, Inc.

Mark S. Blumenkranz, M.D. resigned from the Board of Directors effective September 23, 2024.
He also stepped down from the Audit Committee and Nominating and Corporate Governance Committee.
Resignation was not related to any disagreement with the company's operations, policies, or practices.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark S. Blumenkranz

Director

KALA · KALA BIO, Inc.

Effective: 2024-09-23
Filed: September 25, 2024, 7:59 PM ET

On September 23, 2024, Mark S. Blumenkranz, M.D. notified KALA BIO, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark S. Blumenkranz resigned as Director at KALA BIO, Inc..

Action: resigned
Role: Director

Exact text from the filing

On September 23, 2024, Mark S. Blumenkranz, M.D. notified KALA BIO, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company, effective immediately.

View on SEC.gov

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-102775

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.